These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31581380)

  • 1. Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the Process.
    Kim JS; Kim YR; Yang CS
    J Microbiol Biotechnol; 2019 Oct; 29(10):1506-1521. PubMed ID: 31581380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis.
    Mortaz E; Adcock IM; Tabarsi P; Masjedi MR; Mansouri D; Velayati AA; Casanova JL; Barnes PJ
    J Clin Immunol; 2015 Jan; 35(1):1-10. PubMed ID: 25312698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus.
    Stamm CE; Collins AC; Shiloh MU
    Immunol Rev; 2015 Mar; 264(1):204-19. PubMed ID: 25703561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
    Gopalakrishnan A; Salgame P
    Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity in tuberculosis: host defense vs pathogen evasion.
    Liu CH; Liu H; Ge B
    Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune recognition in tuberculosis infection.
    Tsolaki AG
    Adv Exp Med Biol; 2009; 653():185-97. PubMed ID: 19799120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway.
    Ranjbar S; Jasenosky LD; Chow N; Goldfeld AE
    PLoS Pathog; 2012; 8(4):e1002620. PubMed ID: 22496647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune recognition of Mycobacterium tuberculosis.
    Kleinnijenhuis J; Oosting M; Joosten LA; Netea MG; Van Crevel R
    Clin Dev Immunol; 2011; 2011():405310. PubMed ID: 21603213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor pathways in the immune responses to mycobacteria.
    Quesniaux V; Fremond C; Jacobs M; Parida S; Nicolle D; Yeremeev V; Bihl F; Erard F; Botha T; Drennan M; Soler MN; Le Bert M; Schnyder B; Ryffel B
    Microbes Infect; 2004 Aug; 6(10):946-59. PubMed ID: 15310472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N; Ehlers S; Hölscher C
    Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.
    Faridgohar M; Nikoueinejad H
    Pathog Glob Health; 2017 Jul; 111(5):256-264. PubMed ID: 28715935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?
    Berrington WR; Hawn TR
    Immunol Rev; 2007 Oct; 219():167-86. PubMed ID: 17850489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?
    Hossain MM; Norazmi MN
    Biomed Res Int; 2013; 2013():179174. PubMed ID: 24350246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
    Jo EK
    Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
    Namdev P; Patel S; Sparling B; Garg A
    Front Immunol; 2021; 12():647019. PubMed ID: 33995365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.